CD BioSciences Launches Nanoparticles Imaging Technology for Scientists

Nanoparticles are becoming a versatile tool in biomedical applications, especially in the field of biomedical imaging. Nanoparticles can be utilized for diagnosis, monitoring of physical and pathological processes, therapy and control of biological systems. They are typically smaller than 100 nm in size and can be made of materials with different chemical properties, most commonly metals, metal oxides, silicates, polymers, carbon, lipids and biomolecules. In addition, nanomaterials have diverse surface chemical properties, unique magnetic properties, and tunable absorption and emission properties, and can therefore be designed with different sizes, shapes, chemical surface properties, and hollow, porous, or solid structures.

Nanomaterials have become one of the most powerful imaging tools in molecular imaging due to their diversity and uniqueness. CD Biosciences can synthesize different types of nanoparticles and apply nanotechnology to molecular imaging, allowing researchers to observe cellular functions and biological processes in living organisms in a non-invasive manner for accurate early diagnosis of diseases.

Applications

– In vivo imaging of targeted drug delivery
– Tissue imaging and analysis, and cell imaging analysis
– Digital pathology & imaging analysis
– Detect early-stage diseases, e.g., cancer, cardiac diseases, inflammation, and stroke.

CD BioSciences possesses a professional team with extensive work experience in the imaging field. The team is able to provide clients with personalized imaging services to meet their research needs in the fields of biology, microbiology, medicine and food.

Read the original article on EIN Presswire.